BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36975826)

  • 1. Effects of extended transport on cryopreserved allogeneic hematopoietic progenitor cell (HPC) product quality and optimal methods to assess HPC stability.
    Reddy OL; Sall MT; Dinh A; Cai Y; Ongkeko M; Arya N; Wilder J; Tran M; Jin P; Stroncek DF; Panch SR
    Transfusion; 2023 Apr; 63(4):774-781. PubMed ID: 36975826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells.
    Mfarrej B; Vicari O; Ouffai S; Malenfant C; Granata A; Thevenet S; Chabannon C; Lemarié C; Calmels B
    J Transl Med; 2022 Nov; 20(1):503. PubMed ID: 36329460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
    Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
    Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of cryopreservation on clinically prepared hematopoietic progenitor cell products.
    Winter JM; Jacobson P; Bullough B; Christensen AP; Boyer M; Reems JA
    Cytotherapy; 2014 Jul; 16(7):965-75. PubMed ID: 24910385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.
    Laroye C; Thilly N; Gauthier M; Luc A; Latger-Cannard V; Eschwege V; Bensoussan D; Pochon C; Campidelli A; Rubio MT; D'Aveni M; Decot V
    Cytotherapy; 2023 Aug; 25(8):877-884. PubMed ID: 37178096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
    Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
    Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic.
    Purtill D; Antonenas V; Chiappini P; Tong D; O'Flaherty E; Bajel A; Kabani K; Larsen S; Tan S; Hutchins C; Curtis DJ; Kennedy GA; Watson AM; Bai L; Greenwood M; Gottlieb DJ; Hamad N
    Blood Adv; 2020 Sep; 4(17):4147-4150. PubMed ID: 32886750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.
    Wan BA; Lindo L; Mourad YA; Chung S; Forrest D; Kuchenbauer F; Nantel S; Narayanan S; Nevill T; Power M; Rodrigo J; Sanford D; Song K; Stubbins RJ; Sutherland H; Toze CL; White J; Roy C; Hay KA
    Cytotherapy; 2024 May; ():. PubMed ID: 38819367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
    Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical assessment of the Lovo device for dimethyl sulfoxide removal and cell concentration in thawed hematopoietic progenitor cell grafts.
    Mfarrej B; Bouchet G; Couquiaud J; Regimbaud L; Binninger S; Mercier M; Lemarié C; Houzé P; Chabannon C; Calmels B
    Cytotherapy; 2017 Dec; 19(12):1501-1508. PubMed ID: 29037941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A machine-learning model that incorporates CD45 surface expression predicts hematopoietic progenitor cell recovery after freeze-thaw.
    Al-Riyami AZ; Maryamchik E; Hanna RS; Pashmineh Azar AR; Zheng X; Choudhari S; Finn C; Giacobbe N; Machietto R; Rieser R; Ghasemi Tahrir F; Zhang X; Kadauke S; Wang Y
    Cytotherapy; 2023 Oct; 25(10):1048-1056. PubMed ID: 37318396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and Function of Cryopreserved Bone Marrow from Deceased Organ Donors: A Potential Viable Alternative Graft Source.
    Johnstone BH; Woods JR; Goebel WS; Gu D; Lin CH; Miller HM; Musall KG; Sherry AM; Bailey BJ; Sims E; Sinn AL; Pollok KE; Spellman S; Auletta JJ; Woods EJ
    Transplant Cell Ther; 2023 Feb; 29(2):95.e1-95.e10. PubMed ID: 36402456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
    Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
    Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry.
    Fernandez-Sojo J; Horton R; Cid J; Azqueta C; Garcia-Buendia A; Valdivia E; Martorell L; Rubio-Lopez N; Codinach M; Aran G; Marsal J; Mussetti A; Martino R; Diaz-de-Heredia C; Ferra C; Valcarcel D; Linares M; Ancochea A; García-Rey E; García-Muñoz N; Medina L; Carreras E; Villa J; Lozano M; Gibson D; Querol S
    Bone Marrow Transplant; 2022 Oct; 57(10):1531-1538. PubMed ID: 35804055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting the COVID challenge: Optimizing vCD34
    Chang A; Ragg SJ; Ma DD
    Cytotherapy; 2022 Apr; 24(4):437-443. PubMed ID: 35086777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Viability of Hematopoietic Progenitor Cell Grafts after Cryopreservation Does Not Predict Delayed Engraftment in Allogeneic Hematopoietic Stem Cell Transplantation.
    Fadeyi E; Mamo YT; Saha AK; Wilson E; Pomper G
    Lab Med; 2022 Sep; 53(5):509-513. PubMed ID: 35640044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of a new device for washing and concentrating cryopreserved hematopoietic stem cells and mononuclear cells: a single center experience.
    Santurette CC; Charron M; Bouyer S; Houzé P; Binninger S; Lavergne A; Mercier M; Giraud C
    Cytotherapy; 2022 Jan; 24(1):86-92. PubMed ID: 34690062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased apoptosis in cryopreserved autologous hematopoietic progenitor cells collected by apheresis and delayed neutrophil recovery after transplantation: a nested case-control study.
    Wu L; Al-Hejazi A; Filion L; Ben R; Halpenny M; Yang L; Giulivi A; Allan DS
    Cytotherapy; 2012 Feb; 14(2):205-14. PubMed ID: 21954835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood.
    Yang H; Zhao H; Acker JP; Liu JZ; Akabutu J; McGann LE
    Cryobiology; 2005 Oct; 51(2):165-75. PubMed ID: 16111670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.